View in EDS

Determining the impact of cannabis use on tobacco cessation: Results from a prospective non‐randomized tobacco treatment trial.

Saved in:
Bibliographic Details
Title: Determining the impact of cannabis use on tobacco cessation: Results from a prospective non‐randomized tobacco treatment trial.
Authors: McClure, Erin A., Baker, Nathaniel, Tomko, Rachel L., Walters, Kyle J., Chapman, Elizabeth, Carpenter, Matthew J., Gray, Kevin M.
Source: Addiction. Jul2026, Vol. 121 Issue 7, p1876-1887. 12p.
Subjects: Substance abuse treatment, Clinical drug trials, Carbon monoxide analysis, Smoking cessation, Substance abuse, Cotinine, World Wide Web, Patient compliance, Self-evaluation, Poisson distribution, Research funding, Clinical trials, Probability theory, Questionnaires, Severity of illness index, Descriptive statistics, Experimental design, Contingency management, Motivation (Psychology), Odds ratio, Research methodology, Research, Diary (Literary form), Cannabis (Genus), Tobacco products, Counseling, Application software, Data analysis software, Confidence intervals, Varenicline, Drug abstinence, Cannabinoids, Video recording, Regression analysis
Abstract: Background and aims: Tobacco‐cannabis co‐use is associated with increased psychosocial and health harms; however, the treatment literature assessing the impact of co‐use has been mixed and suffers from critical limitations. To date, no prospective studies have evaluated the degree to which cannabis co‐use affects tobacco cessation, nor are there treatment recommendations for those who co‐use. The goal of this study was to evaluate and quantify the impact of cannabis co‐use on tobacco cessation through a 12‐week prospective tobacco cessation trial. Design: This was a multi‐site, non‐randomized trial. Inverse probability weighted modified Poisson regression models were used to assess the probability of tobacco abstinence between tobacco‐only and tobacco‐cannabis co‐use cohorts. Setting: Enrollment occurred at three sites across South Carolina, USA: The Medical University of South Carolina (MUSC) Charleston, Behavioral Health Services of Pickens County and MUSC Florence. Participants: Enrolled participants were adults (n = 181; ages 18–40) who (1) smoked tobacco cigarettes and used cannabis regularly (co‐use cohort; oversampled) or (2) smoked tobacco cigarettes daily (tobacco‐only cohort). Across 3 sites, 181 adults (110 co‐using cannabis; 71 tobacco‐only) were enrolled (49% female; 19% Black/African American; 6% Hispanic/LatinX). Interventions: All participants received 12 weeks of first‐line tobacco treatment (varenicline, incentives for tobacco abstinence, counseling), while cannabis use was not addressed as part of treatment. Measurements: The primary outcome was biochemically confirmed 7‐day point prevalence tobacco abstinence (PPA) at end of treatment (EOT; Week 12 post‐enrollment). Findings: Average baseline reported cigarettes per day were not different between tobacco‐only or cannabis co‐use cohorts [14.9, (standard deviation, SD = 7.2) versus 13.4 (SD = 7.8); P = 0.25]. Among the co‐use cohort, days of cannabis use in the past month at baseline was 23.7 (SD = 9.5). In imputed analyses, EOT 7‐day PPA tobacco abstinence was achieved in 59% of tobacco‐only participants and 33% of the cannabis co‐use cohort [Imputed data: relative risk (RR) = 1.63, 95% confidence interval (CI) = 1.14–2.33]. Neither baseline daily cannabis use [adjusted relative risk (RRadj) = 1.05, 95% CI = 0.63–1.77] nor within‐treatment cannabis use frequency (RRadj = 0.51, 95% CI = 0.25, 1.06) was associated with EOT PPA for tobacco in the cannabis co‐use cohort. Conclusions: This is the first prospective study designed to compare tobacco cessation outcomes by cannabis co‐use status. Regular cannabis co‐use had a negative impact on tobacco abstinence among younger to middle‐aged adults. Addressing cannabis use should be incorporated into standard tobacco treatment to improve cessation outcomes. [ABSTRACT FROM AUTHOR]
Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 194810805
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Determining the impact of cannabis use on tobacco cessation: Results from a prospective non‐randomized tobacco treatment trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22McClure%2C+Erin+A%2E%22">McClure, Erin A.</searchLink><br /><searchLink fieldCode="AR" term="%22Baker%2C+Nathaniel%22">Baker, Nathaniel</searchLink><br /><searchLink fieldCode="AR" term="%22Tomko%2C+Rachel+L%2E%22">Tomko, Rachel L.</searchLink><br /><searchLink fieldCode="AR" term="%22Walters%2C+Kyle+J%2E%22">Walters, Kyle J.</searchLink><br /><searchLink fieldCode="AR" term="%22Chapman%2C+Elizabeth%22">Chapman, Elizabeth</searchLink><br /><searchLink fieldCode="AR" term="%22Carpenter%2C+Matthew+J%2E%22">Carpenter, Matthew J.</searchLink><br /><searchLink fieldCode="AR" term="%22Gray%2C+Kevin+M%2E%22">Gray, Kevin M.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Addiction%22">Addiction</searchLink>. Jul2026, Vol. 121 Issue 7, p1876-1887. 12p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Substance+abuse+treatment%22">Substance abuse treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+drug+trials%22">Clinical drug trials</searchLink><br /><searchLink fieldCode="DE" term="%22Carbon+monoxide+analysis%22">Carbon monoxide analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Smoking+cessation%22">Smoking cessation</searchLink><br /><searchLink fieldCode="DE" term="%22Substance+abuse%22">Substance abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Cotinine%22">Cotinine</searchLink><br /><searchLink fieldCode="DE" term="%22World+Wide+Web%22">World Wide Web</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+compliance%22">Patient compliance</searchLink><br /><searchLink fieldCode="DE" term="%22Self-evaluation%22">Self-evaluation</searchLink><br /><searchLink fieldCode="DE" term="%22Poisson+distribution%22">Poisson distribution</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink><br /><searchLink fieldCode="DE" term="%22Probability+theory%22">Probability theory</searchLink><br /><searchLink fieldCode="DE" term="%22Questionnaires%22">Questionnaires</searchLink><br /><searchLink fieldCode="DE" term="%22Severity+of+illness+index%22">Severity of illness index</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Experimental+design%22">Experimental design</searchLink><br /><searchLink fieldCode="DE" term="%22Contingency+management%22">Contingency management</searchLink><br /><searchLink fieldCode="DE" term="%22Motivation+%28Psychology%29%22">Motivation (Psychology)</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink><br /><searchLink fieldCode="DE" term="%22Research+methodology%22">Research methodology</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22Diary+%28Literary+form%29%22">Diary (Literary form)</searchLink><br /><searchLink fieldCode="DE" term="%22Cannabis+%28Genus%29%22">Cannabis (Genus)</searchLink><br /><searchLink fieldCode="DE" term="%22Tobacco+products%22">Tobacco products</searchLink><br /><searchLink fieldCode="DE" term="%22Counseling%22">Counseling</searchLink><br /><searchLink fieldCode="DE" term="%22Application+software%22">Application software</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis+software%22">Data analysis software</searchLink><br /><searchLink fieldCode="DE" term="%22Confidence+intervals%22">Confidence intervals</searchLink><br /><searchLink fieldCode="DE" term="%22Varenicline%22">Varenicline</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+abstinence%22">Drug abstinence</searchLink><br /><searchLink fieldCode="DE" term="%22Cannabinoids%22">Cannabinoids</searchLink><br /><searchLink fieldCode="DE" term="%22Video+recording%22">Video recording</searchLink><br /><searchLink fieldCode="DE" term="%22Regression+analysis%22">Regression analysis</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background and aims: Tobacco‐cannabis co‐use is associated with increased psychosocial and health harms; however, the treatment literature assessing the impact of co‐use has been mixed and suffers from critical limitations. To date, no prospective studies have evaluated the degree to which cannabis co‐use affects tobacco cessation, nor are there treatment recommendations for those who co‐use. The goal of this study was to evaluate and quantify the impact of cannabis co‐use on tobacco cessation through a 12‐week prospective tobacco cessation trial. Design: This was a multi‐site, non‐randomized trial. Inverse probability weighted modified Poisson regression models were used to assess the probability of tobacco abstinence between tobacco‐only and tobacco‐cannabis co‐use cohorts. Setting: Enrollment occurred at three sites across South Carolina, USA: The Medical University of South Carolina (MUSC) Charleston, Behavioral Health Services of Pickens County and MUSC Florence. Participants: Enrolled participants were adults (n = 181; ages 18–40) who (1) smoked tobacco cigarettes and used cannabis regularly (co‐use cohort; oversampled) or (2) smoked tobacco cigarettes daily (tobacco‐only cohort). Across 3 sites, 181 adults (110 co‐using cannabis; 71 tobacco‐only) were enrolled (49% female; 19% Black/African American; 6% Hispanic/LatinX). Interventions: All participants received 12 weeks of first‐line tobacco treatment (varenicline, incentives for tobacco abstinence, counseling), while cannabis use was not addressed as part of treatment. Measurements: The primary outcome was biochemically confirmed 7‐day point prevalence tobacco abstinence (PPA) at end of treatment (EOT; Week 12 post‐enrollment). Findings: Average baseline reported cigarettes per day were not different between tobacco‐only or cannabis co‐use cohorts [14.9, (standard deviation, SD = 7.2) versus 13.4 (SD = 7.8); P = 0.25]. Among the co‐use cohort, days of cannabis use in the past month at baseline was 23.7 (SD = 9.5). In imputed analyses, EOT 7‐day PPA tobacco abstinence was achieved in 59% of tobacco‐only participants and 33% of the cannabis co‐use cohort [Imputed data: relative risk (RR) = 1.63, 95% confidence interval (CI) = 1.14–2.33]. Neither baseline daily cannabis use [adjusted relative risk (RRadj) = 1.05, 95% CI = 0.63–1.77] nor within‐treatment cannabis use frequency (RRadj = 0.51, 95% CI = 0.25, 1.06) was associated with EOT PPA for tobacco in the cannabis co‐use cohort. Conclusions: This is the first prospective study designed to compare tobacco cessation outcomes by cannabis co‐use status. Regular cannabis co‐use had a negative impact on tobacco abstinence among younger to middle‐aged adults. Addressing cannabis use should be incorporated into standard tobacco treatment to improve cessation outcomes. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=194810805
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/add.70382
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1876
    Subjects:
      – SubjectFull: Substance abuse treatment
        Type: general
      – SubjectFull: Clinical drug trials
        Type: general
      – SubjectFull: Carbon monoxide analysis
        Type: general
      – SubjectFull: Smoking cessation
        Type: general
      – SubjectFull: Substance abuse
        Type: general
      – SubjectFull: Cotinine
        Type: general
      – SubjectFull: World Wide Web
        Type: general
      – SubjectFull: Patient compliance
        Type: general
      – SubjectFull: Self-evaluation
        Type: general
      – SubjectFull: Poisson distribution
        Type: general
      – SubjectFull: Research funding
        Type: general
      – SubjectFull: Clinical trials
        Type: general
      – SubjectFull: Probability theory
        Type: general
      – SubjectFull: Questionnaires
        Type: general
      – SubjectFull: Severity of illness index
        Type: general
      – SubjectFull: Descriptive statistics
        Type: general
      – SubjectFull: Experimental design
        Type: general
      – SubjectFull: Contingency management
        Type: general
      – SubjectFull: Motivation (Psychology)
        Type: general
      – SubjectFull: Odds ratio
        Type: general
      – SubjectFull: Research methodology
        Type: general
      – SubjectFull: Research
        Type: general
      – SubjectFull: Diary (Literary form)
        Type: general
      – SubjectFull: Cannabis (Genus)
        Type: general
      – SubjectFull: Tobacco products
        Type: general
      – SubjectFull: Counseling
        Type: general
      – SubjectFull: Application software
        Type: general
      – SubjectFull: Data analysis software
        Type: general
      – SubjectFull: Confidence intervals
        Type: general
      – SubjectFull: Varenicline
        Type: general
      – SubjectFull: Drug abstinence
        Type: general
      – SubjectFull: Cannabinoids
        Type: general
      – SubjectFull: Video recording
        Type: general
      – SubjectFull: Regression analysis
        Type: general
    Titles:
      – TitleFull: Determining the impact of cannabis use on tobacco cessation: Results from a prospective non‐randomized tobacco treatment trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McClure, Erin A.
      – PersonEntity:
          Name:
            NameFull: Baker, Nathaniel
      – PersonEntity:
          Name:
            NameFull: Tomko, Rachel L.
      – PersonEntity:
          Name:
            NameFull: Walters, Kyle J.
      – PersonEntity:
          Name:
            NameFull: Chapman, Elizabeth
      – PersonEntity:
          Name:
            NameFull: Carpenter, Matthew J.
      – PersonEntity:
          Name:
            NameFull: Gray, Kevin M.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 09652140
          Numbering:
            – Type: volume
              Value: 121
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Addiction
              Type: main
ResultId 1